138 related articles for article (PubMed ID: 20150361)
1. Chromosome 9p and 10q losses predict unfavorable outcome in low-grade gliomas.
Houillier C; Mokhtari K; Carpentier C; Crinière E; Marie Y; Rousseau A; Kaloshi G; Dehais C; Laffaire J; Laigle-Donadey F; Hoang-Xuan K; Sanson M; Delattre JY
Neuro Oncol; 2010 Jan; 12(1):2-6. PubMed ID: 20150361
[TBL] [Abstract][Full Text] [Related]
2. Loss of 1p, 19q, and 10q heterozygosity prospectively predicts prognosis of oligodendroglial tumors--towards individualized tumor treatment?
Ramirez C; Bowman C; Maurage CA; Dubois F; Blond S; Porchet N; Escande F
Neuro Oncol; 2010 May; 12(5):490-9. PubMed ID: 20156805
[TBL] [Abstract][Full Text] [Related]
3. Prognostic stratification of patients with anaplastic gliomas according to genetic profile.
Dehais C; Laigle-Donadey F; Marie Y; Kujas M; Lejeune J; Benouaich-Amiel A; Pedretti M; Polivka M; Xuan KH; Thillet J; Delattre JY; Sanson M
Cancer; 2006 Oct; 107(8):1891-7. PubMed ID: 16986124
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity on chromosomes 10q, 9p, 17p and 13q in malays with malignant glioma.
Zainuddin N; Jaafart H; Isa MN; Abdullah JM
Neurol Res; 2004 Jan; 26(1):88-92. PubMed ID: 14977064
[TBL] [Abstract][Full Text] [Related]
5. Contribution of 1p, 19q, 9p and 10q Automated Analysis by FISH to the Diagnosis and Prognosis of Oligodendroglial Tumors According to WHO 2016 Guidelines.
Michaud K; de Tayrac M; D'Astous M; Duval C; Paquet C; Samassekou O; Gould PV; Saikali S
PLoS One; 2016; 11(12):e0168728. PubMed ID: 28030632
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity for loci on chromosome arms 1p and 10q in oligodendroglial tumors: relationship to outcome and chemosensitivity.
Thiessen B; Maguire JA; McNeil K; Huntsman D; Martin MA; Horsman D
J Neurooncol; 2003 Sep; 64(3):271-8. PubMed ID: 14558604
[TBL] [Abstract][Full Text] [Related]
7. Loss of 22q chromosome is related to glioma progression and loss of 10q.
Laigle-Donadey F; Crinière E; Benouaich A; Lesueur E; Mokhtari K; Hoang-Xuan K; Sanson M
J Neurooncol; 2006 Feb; 76(3):265-8. PubMed ID: 16283437
[TBL] [Abstract][Full Text] [Related]
8. Molecular heterogeneity of oligodendrogliomas suggests alternative pathways in tumor progression.
Hoang-Xuan K; He J; Huguet S; Mokhtari K; Marie Y; Kujas M; Leuraud P; Capelle L; Delattre JY; Poirier J; Broët P; Sanson M
Neurology; 2001 Oct; 57(7):1278-81. PubMed ID: 11591848
[TBL] [Abstract][Full Text] [Related]
9. Analysis of 1p, 19q, 9p, and 10q as prognostic markers for high-grade astrocytomas using fluorescence in situ hybridization on tissue microarrays from Radiation Therapy Oncology Group trials.
Brat DJ; Seiferheld WF; Perry A; Hammond EH; Murray KJ; Schulsinger AR; Mehta MP; Curran WJ;
Neuro Oncol; 2004 Apr; 6(2):96-103. PubMed ID: 15134623
[TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of 1p and 19q deletion for patients with WHO grade 2 and 3 gliomas.
Iwamoto FM; Nicolardi L; Demopoulos A; Barbashina V; Salazar P; Rosenblum M; Hormigo A
J Neurooncol; 2008 Jul; 88(3):293-8. PubMed ID: 18345516
[TBL] [Abstract][Full Text] [Related]
11. Gliomas: association of histology and molecular genetic analysis of chromosomes 1p, 10q, and 19q.
Gresner SM; Rieske P; Wozniak K; Piaskowski S; Jaskolski DJ; Skowronski W; Sikorska B; Papierz W; Liberski PP
Acta Neurobiol Exp (Wars); 2007; 67(2):103-12. PubMed ID: 17691218
[TBL] [Abstract][Full Text] [Related]
12. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.
Cairncross JG; Ueki K; Zlatescu MC; Lisle DK; Finkelstein DM; Hammond RR; Silver JS; Stark PC; Macdonald DR; Ino Y; Ramsay DA; Louis DN
J Natl Cancer Inst; 1998 Oct; 90(19):1473-9. PubMed ID: 9776413
[TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity 1p/19q and survival in glioma: a meta-analysis.
Zhao J; Ma W; Zhao H
Neuro Oncol; 2014 Jan; 16(1):103-12. PubMed ID: 24311641
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of chromosome 1, 10 and 19 abnormalities in human oligodendroglial tumors: relationship between frequency of LOH grade, age and gender.
Gresner SM; Rieske P; Wozniak K; Piaskowski S; Jaskolski DJ; Skowronski W; Golanska E; Sikorska B; Liberski PP
Clin Neuropathol; 2006; 25(1):18-24. PubMed ID: 16465770
[TBL] [Abstract][Full Text] [Related]
15. Association between fluorine-18-labeled fluorodeoxyglucose uptake and 1p and 19q loss of heterozygosity in World Health Organization Grade II gliomas.
Stockhammer F; Thomale UW; Plotkin M; Hartmann C; Von Deimling A
J Neurosurg; 2007 Apr; 106(4):633-7. PubMed ID: 17432715
[TBL] [Abstract][Full Text] [Related]
16. Chromosomal alterations in oligodendroglial tumours over multiple surgeries: is tumour progression associated with change in 1p/19q status?
Campbell BA; Horsman DE; Maguire J; Young S; Curman D; Ma R; Thiessen B
J Neurooncol; 2008 Aug; 89(1):37-45. PubMed ID: 18458822
[TBL] [Abstract][Full Text] [Related]
17. Chromosome 1p loss: a favorable prognostic factor in low-grade gliomas.
Kujas M; Lejeune J; Benouaich-Amiel A; Crinière E; Laigle-Donadey F; Marie Y; Mokhtari K; Polivka M; Bernier M; Chretien F; Couvelard A; Capelle L; Duffau H; Cornu P; Broët P; Thillet J; Carpentier AF; Sanson M; Hoang-Xuan K; Delattre JY
Ann Neurol; 2005 Aug; 58(2):322-6. PubMed ID: 16049942
[TBL] [Abstract][Full Text] [Related]
18. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
19. Spatial and temporal evolution of distal 10q deletion, a prognostically unfavorable event in diffuse low-grade gliomas.
van Thuijl HF; Scheinin I; Sie D; Alentorn A; van Essen HF; Cordes M; Fleischeuer R; Gijtenbeek AM; Beute G; van den Brink WA; Meijer GA; Havenith M; Idbaih A; Hoang-Xuan K; Mokhtari K; Verhaak RG; van der Valk P; van de Wiel MA; Heimans JJ; Aronica E; Reijneveld JC; Wesseling P; Ylstra B
Genome Biol; 2014 Sep; 15(9):471. PubMed ID: 25245118
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of 1p, 19q, 9p, 10q, and EGFR-FISH analyses in recurrent oligodendrogliomas.
Fallon KB; Palmer CA; Roth KA; Nabors LB; Wang W; Carpenter M; Banerjee R; Forsyth P; Rich K; Perry A
J Neuropathol Exp Neurol; 2004 Apr; 63(4):314-22. PubMed ID: 15099021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
